drugset / Trial / NCT02753166

Dexamethasone as an Immediate Intervention

NCT02753166 ↗

Phase 1 Withdrawn NYU Langone Health
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine if a single dose of dexamethasone (5 mg) administered in the first 12 hours following a potentially traumatic event alters a) cortisol and FKBP5 RNA the next day in the periphery measured in saliva; b) FKBP5 methylation by 1 month; c) executive functioning and emotion regulation functioning; d) psychophysiological (heart rate, respiration, skin conductance) in response cued reminders of the trauma; e) enhances the likelihood of remission of PTSD symptom severity.

Timeline

Start
2017-01
Primary completion
2017-12-12
Completion
2017-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 5 mg —

Indications

No indication recorded.